 management transitional cell carcinoma solitary renal units patients urothelial malignancies solitary functioning renal unit center average months death patients parenchyma-sparing methods percutaneous ureteroscopic tumor resection patients adjunctive chemotherapy form bacillus Calmette-Guerin instillations time report patients alive evidence disease alive evidence residual recurrent neoplasia dead disease years original presentation Patients grade tumors carcinoma situ patients low grade disease analysis experience complex patient population implications data context literature topic upper tract urothelial malignancy